n-methylaspartate has been researched along with Acquired Metabolic Diseases, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decker, H; Molz, S; Tasca, CI; Tharine, DC | 1 |
| De Strooper, B; Dewachter, I; Lorent, K; Moechars, D; Van Leuven, F | 1 |
2 other study(ies) available for n-methylaspartate and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
Topics: Animals; Aspartic Acid; Brain Diseases, Metabolic; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Guanosine Monophosphate; Hippocampus; Male; N-Methylaspartate; Neuroprotective Agents; Neurotoxins; Organ Culture Techniques; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Vesicular Glutamate Transport Proteins | 2008 |
Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice.
Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Behavior, Animal; Brain; Brain Diseases, Metabolic; Endopeptidases; Excitatory Amino Acid Agonists; Hyperkinesis; Kainic Acid; Mice; Mice, Transgenic; Mutation; N-Methylaspartate; Neurons; Protein Processing, Post-Translational; Seizures | 1996 |